Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5ZG92 | IM / RA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 95BJ9 | IM / RA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | DN273 | IM / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y012594 | SC / LA |
Patient was administered an additional dose of MMRV and hep B. The first doses of MMR and varicella were initially administered 1/29/25. Due to an error of verification from a medical assistant, the patient received another dose of MMRV and hep B on 2/4/25. Patients mother reported patient to have fever as a side effect which occurred 2/4/25. Patients mother reported fever to last only 3 days. Patients mother gave Tylenol to help with fever. Patients mother reported patient to have overcome fever.
No known illnesses
No known chronic or long-standing health conditions
No known medications
No known allergies